REDWOOD CITY, Calif.,
Jan. 22, 2015 /PRNewswire/ --
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release
financial results for its fiscal second quarter ended December 31, 2014, on Thursday, February 5, 2015, after the markets
close. Cardica's management will host a conference call at
4:30 p.m. Eastern Time to discuss the
financial results and provide an update on the company's
business.
Conference Call Details
To access the live conference
call on February 5, 2015, at
4:30 p.m. Eastern Time via phone,
please dial 866-318-8611 from the United
States and Canada or
617-399-5130 internationally. The conference ID is 61582374. Please
dial in approximately 10 minutes prior to the start of the call. A
telephone replay will be available beginning approximately four
hours after the call through February 12,
2015, and may be accessed by dialing 888-286-8010 from
the United States and Canada or 617-801-6888 internationally. The
replay passcode is 17913151.
To access the live and subsequently archived webcast of the
conference call, go to the Investor Relations section of the
company's website at www.cardica.com. Please connect to the website
at least 15 minutes prior to the presentation to allow for any
necessary software downloads.
The webcast is also being distributed through the Thomson
StreetEvents Network. Institutional investors can access the call
via Thomson StreetEvents at www.streetevents.com, a
password-protected event management site.
About Cardica
Cardica designs and manufactures
proprietary stapling and anastomotic devices for cardiac and
laparoscopic surgical procedures. Cardica's technology
portfolio is intended to reduce operating time and facilitate
minimally-invasive and robot-assisted surgeries. Cardica's
MicroCutter XCHANGE® 30, a cartridge-based articulating
surgical stapling device with a five-millimeter shaft diameter, is
manufactured and cleared for use in a variety of gastrointestinal
procedures and appendectomies in the
United States, and for a wide range of surgical procedures
in Europe. Cardica is
developing the Cardica® MicroCutter XCHANGE®
45, a cartridge-based microcutter device that is being designed
with an eight-millimeter shaft to be used in a variety of
procedures, including bariatric, colorectal, thoracic and general
surgery. The Cardica MicroCutter XCHANGE 45 product requires 510(k)
clearance and CE Mark and is not yet commercially available in the
U.S. or internationally. In addition, Cardica manufactures and
markets its automated anastomosis systems, the C-Port®
Distal Anastomosis Systems and PAS-Port® Proximal
Anastomosis System for coronary artery bypass graft (CABG) surgery,
and has shipped over 53,000 units throughout the world.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cardica-to-announce-fiscal-2015-second-quarter-financial-results-on-thursday-february-5-2015-300024061.html
SOURCE Cardica, Inc.